EcoDrugPlus

Mast Cell Protease 2

Ensembl ID : ENSBMUG00000010900
Gene Symbol: LOC102281128
2 Cross references
277 Possible Orthologues:

Matrix Metallopeptidase 12

Ensembl ID : ENSBMUG00000024977
Gene Symbol: MMP12
3 Cross references
560 Possible Orthologues:

Matrix Metallopeptidase 13

Ensembl ID : ENSBMUG00000024971
Gene Symbol: MMP13
3 Cross references
202 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSBMUG00000018824
Gene Symbol: MMP14
3 Cross references
272 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSBMUG00000010148
Gene Symbol: MMP2
3 Cross references
210 Possible Orthologues:

Matrix Metallopeptidase 3

Ensembl ID : ENSBMUG00000025047
Gene Symbol: MMP3
3 Cross references
502 Possible Orthologues:

Matrix Metallopeptidase 7

Ensembl ID : ENSBMUG00000005974
Gene Symbol: MMP7
3 Cross references
163 Possible Orthologues:

Matrix Metallopeptidase 8

Ensembl ID : ENSBMUG00000005917
Gene Symbol: MMP8
3 Cross references
111 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSBMUG00000005456
Gene Symbol: MMP9
3 Cross references
216 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSBMUG00000001073
Gene Symbol: MTOR
3 Cross references
224 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSBMUG00000011537
Gene Symbol: MC1R
1 Cross references
159 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSBMUG00000016410
Gene Symbol: MC3R
3 Cross references
137 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).